Correlation and Identification of variable number of tandem repeats of eNOS gene in coronary artery disease (CAD)

Saudi Journal of Biological Sciences

Volumn 17, Issue 3, 2010, Pages 209-213

  Syed, Rabbani ^a   Biyabani, Moin Uddin ^a   Prasad, Shiva ^a   Deeba, Farha ^a   Jamil, Kaiser ^a  

^a Bhagwan Mahavir Medical Research Centre   (India)

Author keywords

Coronary artery disease (CAD); Gene polymorphism; Nitric oxide (NO); Nitric oxide synthase

Indexed keywords

EID: 77958161070     PISSN: 1319562X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sjbs.2010.04.003     Document Type: Article

References (37)

1. Bergholm, R., Tiikkainen, M., Vehkavaara, S., Tamminen, M., Teramo, K., Rissanen, A., Yki-Jarvinen, H., 2003. Lowering of LDL cholesterol rather than moderate weight loss improves endothelium-dependent vasodilatation in obese women with previous gestational diabetes. Diabetes Care 26 (6), 1667-1672 (98).
2. Bloodsworth, A., O'Donnell, V.B., Freeman, B.A., 2000. Nitric oxide regulation of free radical- and enzyme-mediated lipid and lipoprotein oxidation. Arterioscler. Thromb. Vasc. Biol. 20, 1707-1715.
3. Cavalli, S.A., Hirata, M.H., Salazar, L.A., Diament, J., Forti, N., Giannini, S.D., et al., 2000. Apolipoprotein B gene polymorphisms: prevalence and impact on serum lipid concentrations in hypercholesterolemic individuals from Brazil. Clin. Chim. Acta 302, 189-203 (IHJ-).
4. Celermajer, D.S., Adams, M.R., Clarkson, P., Robinson, J., McCredie, R., Donald, A., Deanfield, J.E., 1996. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N. Engl. J. Med. 334 (3), 150-154.
5. Celermajer, D.S., Sorensen, K.E., Spiegelhalter, D.J., Georgakopoulos, D., Robinson, J., Deanfield, J.E., 1994. Aging is associated with endothelial dysfunction in healthy men years before the agerelated decline in women. J. Am. Coll. Cardiol. 24 (2), 471-476.
6. Emery, A.E.H., 1976. Hardy Weinberg equilibrium: the estimation of gene frequencies. In: Emery, A.E.H. (Ed.), Methodology in Medical Genetics: An Introduction to Statistical Methods. Churchill Livingstone, Edinburgh, Scotland, pp. 3-9.
7. Furchogott, R.F., 1990. Studies on endothelium-dependent vasodilatation and the endothelium-derived relaxing factor. Acta Physiol. Scand. 139, 257-270.
8. Franzoni, F., Ghiadoni, L., Galetta, F., Plantinga, Y., Lubrano, V., Huang, Y., Salvetti, G., Regoli, F., Taddei, S., Santoro, G., Salvetti, A., 2005. Physical activity, plasma antioxidant capacity, and endothelium-dependent vasodilation in young and older men. Am. J. Hypertens. 18 (4 Pt 1), 510-516.
9. Gardemann, A., Lohre, J., Cayci, S., Katz, N., Tillmanns, H., Haberbosch, W., 2002. The T allele of the missense Glu298Asp endothelial nitric oxide synthase gene polymorphism is associated with coronary heart disease in younger individuals with high atherosclerosis risk profile. Atherosclerosis 160, 167-175.
10. Hibi, K., Ishigami, T., Tamura, K., Mizushima, S., Nyui, N., Fujita, T., et al., 1998. Endothelial nitric oxide synthase gene polymorphism and acute myocardial infraction. Hypertension 32, 521-526.
11. Hayden, M.R., 2001. Atherosclerosis and plaque angiogenesis: a malignant transformation. Pathology and clinical classification of vulnerable plaque. Biochem. J. 357 (3), 593-615.
12. Hayden, M.R., Tyagi, S.C., 2002. Intimal redox stress: accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus; atheroscleropathy. Cardiovasc. Diabetol. 1, 3. doi:10.1186/1475-2840-1-3.
13. Hayden, M.R., Tyagi, S.C., 1998a. Arterial vascular remodeling: the endothelial cell's central role. Mo. Med. 95 (5), 213-217.
14. Hayden, M.R., Tyagi, S.C., 1998b. Chapter. Atherosclerosis: implications of angiotensin II and the AT-1 receptor. In: Dhalla, N.S., Zahradka, P., Dixon, I., Beamish, R. (Eds.),. In: Angiotensin II Receptor Blockade: Physiological and Clinical Implications, vol. 2. Kluwer Academic Publishers, Boston, MA, pp. 233-243.
15. Hayden, M.R., Tyagi, S.C., 2000. Arteriogenesis: angiogenesis within unstable atherosclerotic plaques-interactions with extracellular matrix. Curr. Interv. Cardiol. Rep. 2 (3), 218-227.
16. Heitzer, T., Yla-Herttuala, S., Luoma, J., Kurz, S., Munzel, T., Just, H., Olschewski, M., Drexler, H., 1996. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL. Circulation 93 (7), 1346-1353.
17. Ignarro, L.J., Fukuto, J.M., Griscavage, J.M., Rogers, N.E., Byrns, R.E., 1993. Oxidation of nitric oxide in aqueous solution to nitrite but not nitrate: comparison with enzymatically formed nitric oxide from L-arginine. Proc. Natl. Acad. Sci. USA 90, 8103-8107.
18. Ichihara, S., Yamada, Y., Fujimura, T., Nakashima, N., Yokota, M., 1998. Association of a polymorphism of the endothelial constitutive nitric oxide synthase gene with myocardial infraction in the Japanese population. Am. J. Cardiol. 18, 83-86.
19. Linder, L., Kiowski, W., Buhler, F.R., Luscher, T.F., 1990. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension. Circulation 81 (6), 1762-1767.
20. Marsden, P.A., Heng, H.H., Scherer, S.W., Stewart, R.J., Hall, A.V., Shi, X.M., et al., 1993. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J. Biol. Chem. 268, 17478-17488.
21. Matyar, S., Attila, G., Acarturk, E., Akpinar, O., Inal, T., 2005. ENOS gene intron 4 a/b VNTR polymorphism is a risk factor for coronary artery disease in Southern Turkey. Clin. Chim. Acta 354, 153-158.
22. Meigs, J.B., O'donnell, C.J., Tofler, G.H., Benjamin, E.J., Fox, C.S., Lipinska, I., Nathan, D.M., Sullivan, L.M., D'Agostino, R.B., Wilson, P.W., 2006. Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham offspring study. Diabetes 55 (2), 530-537.
23. Moreel, J.F., Roizes, G., Evans, A.E., Arveiler, D., Cambou, J.P., Souriau, C., et al., 1992. The polymorphism ApoB/4311 in patients with myocardial infarction and controls: the ECTIM study. Hum. Genet. 89, 169-175.
24. Patel, R.P., Levonen, A., Crawford, J.H., Darley-Usmar, V.M., 2000. Mechanisms of the pro- and anti-oxidant actions of nitric oxide in atherosclerosis. Cardiovasc. Res. 47, 465-474.
25. Park, J.E., Lee, W.H., Hwang, T.H., Chu, J.A., Kim, S., Choi, Y.H., et al., 2000. Aging affects the association between endothelial nitric oxide synthase gene polymorphism and acute myocardial infraction in the Korean male population. Korean J. Int. Med. 15, 65-70.
26. Salami, Saeedeh, Firoozrai, Mohsen, Nourmohammadi, Issa, Shabani, Mohammad, Mohebbi, Ahmad, 2006. Endothelial nitric oxide synthase gene intron4 VNTR polymorphism in patients with coronary artery disease in Iran. Indian J. Med. Res. 124, 683-688.
27. Steinberg, H.O., Chaker, H., Leaming, R., Johnson, A., Brechtel, G., Baron, A.D., 1996. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J. Clin. Invest. 97 (11), 2601-2610.
28. Stehbens, W.E., 1990. The epidemiological relationship of hypercholesterolemia, hypertension, diabetes mellitus and obesity to coronary heart disease and atherogenesis. J. Clin. Epidemiol. 43 (8), 733-741.
29. Stangl, K., Cascorbi, I., Laule, M., 2000. High CA repeat numbers in intron 13 of the endothelial nitric oxide synthase gene and increased risk of coronary artery disease. Pharmacogenetics 10, 133-140.
30. Shoji, M., Tsutaya, S., Saito, R., Takamato, H., Yasujimi, M., 2000. Positive association of endothelial nitric oxide synthase gene polymorphism with hypertension in Northern Japan. Life Sci. 66, 2557-2562.
31. Uthra, Satagopan, Raman, Rajiv, Mukesh, Bickol N., Padmaja, Kumari R., Paul, Pradeep G., Lakshmipathy, Praveena, Gnanamoorthy, Perumal, Sharma, Tarun, McCarty, Catherine A., Kumaramanickavel, Govindasamy, 2007. Intron 4 VNTR of endothelial nitric oxide synthase (eNOS) gene and diabetic retinopathy in type 2 patients in southern India. Ophthalmic Genet. 28(20), 77-81.
32. Suryanarayana, Venkata, Rao, Lakshmi, Kanakavalli, Murthy, Padmalatha, Venkata, Deenadayal, Mamata, Singh, Lalji, 2005. Recurrent Early Pregnancy Loss and Endothelial Nitric Oxide Synthase Gene Polymorphisms, vol. 274. Springer, Berlin, pp. 119-124.
33. Wang, X.L., Sim, A.S., Badenhop, R.F., McCredie, R.M., Wilcken, D.E., 1996. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat. Med. 2, 41-45.
34. Wang, X.L., Mahaney, M.C., Sim, A.S., Wang, J., Wang, J., Blangero, J., et al., 1997. Genetic contribution of endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler. Thromb. Vasc. Biol. 17, 3147-3153.
35. Wang, X.L., Wang, J., 2000. Endothelial nitric oxide synthase gene sequence variations and vascular disease. Mol. Genet. Metab. 70, 241-251.
36. Yashimura, M., Yasue, H., Nakayama, M., Shimasaki Sumida, H., Sugiyama, S., et al., 1998. A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spam in the Japanese. Hum. Genet. 103, 65-69.
37. Yashimura, M., Yasue, H., Nakayama, M., Kujiyama, K., Saito, Y., Miamoto, Y., et al., 2000. Risk factors for coronary artery spam: significance of endothelial nitric oxide synthase gene T-786C and missence Glu298Asp variants. J. Invest. Med. 48, 367-374.